An interventional study of Same Day Discharge - Video-Assisted Thoracoscopic Surgery (VATS) Lung in Lung Cancer and Surgery, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. Status unknown at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-10-18.
Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre · Not applicable, Interventional, and Treatment
Phase I to evaluate the safety and feasibility of same-day discharge in selected participants undergoing minimally-invasive lung surgery and who receive an enhanced recovery pathway.
McGill University Health Centre/Research Institute of the McGill University Health Centre is the lead sponsor of 414 studies on the registry; 106 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients with stage I or II primary lung cancer or pulmonary metastasis scheduled to undergo surgery.
Procedure: Same Day Discharge - Video-Assisted Thoracoscopic Surgery (VATS) Lung
All patients will be scheduled to surgery at the start of the day and will be discharged within the same day as the procedure.
Adverse Event Rate
Time frame: 30 days post surgery
Same Day Discharge Rate
Time frame: Throughout the trial, from start until completion of surgery for all the patients, up to 12 months.
Readmission Rate
Time frame: 30 days post surgery
Rate of presentation to the emergency room after surgery
Time frame: 30 days post surgery
Edmonton Symptom Assessment Scale (ESAS)
Rating pain, fatigue, nausea, depression, anxiety, drowsiness, appetite, well-being and shortness of breath, on a scale of 1 to 10. Higher scores indicate more serious symptoms.
Time frame: 30 days post surgery
Functional Assessment of Cancer Therapy - Lung (FACT-L)
Rating questions regarding physical, social/family, emotion and function well-being as well as general questions regarding medical health, on a scale of 0-4 (from 'Not at all' to 'Very much').
Time frame: 30 days post surgery
Duration of indwelling chest tube catheter
Time frame: 30 days post surgery or until the chest tube is removed (whichever comes last, assessed until 90 days post surgery)
Rate of screen failure
Feasibility calculation of the number of patients approached to participate compared to the number of patients consented to the trial.
Time frame: From trial start until last patient consented, up to 12 months.
Percent of eligible participants consented
Time frame: From trial start until last patient consented, up to 12 months.
Pathway adherence rate
Calculation of the number of participants who stay on the same-day discharge pathway versus number of patients who deviate from the protocol.
Time frame: From moment of consent until 1 day post surgery.
Documents are hosted by the registry — open the source record to download them.
Plan to share: Undecided
This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
McGill University Health Centre/Research Institute of the McGill University Health Centre